Helix BioMedix Inc. (OTCMKTS:HXBM – Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 87 shares, a drop of 57.4% from the August 31st total of 204 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 901 shares, the short-interest ratio is currently 0.1 days.
Helix BioMedix Price Performance
Helix BioMedix stock remained flat at $4.40 during mid-day trading on Tuesday. 100 shares of the company’s stock were exchanged, compared to its average volume of 261. Helix BioMedix has a 12-month low of $1.00 and a 12-month high of $6.50. The stock’s 50 day simple moving average is $3.15 and its 200 day simple moving average is $2.07.
Helix BioMedix Company Profile
Helix BioMedix, Inc is a biotechnology company focused on the discovery, development and commercialization of bioactive peptides for personal-care, cosmetic and related life-science applications. Its work centers on peptides designed to support skin health and appearance, including products used in anti-aging, skin-repair and antimicrobial formulations.
The company develops proprietary peptide ingredients and licenses or supplies them to manufacturers and formulators for use in skincare and other topical products.
Further Reading
- Five stocks we like better than Helix BioMedix
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
- Tesla’s Semi Is Finally Here—But Will It Move the Stock?
- 5 Stocks Showing Why Pricing Power Matters More Than Government Money
- Rocket Lab Bounces Off Its Lows—What’s Behind the Move?
Receive News & Ratings for Helix BioMedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helix BioMedix and related companies with MarketBeat.com's FREE daily email newsletter.
